Eligibility criteria
Condition
Rheumatoid Arthritis
Sex
Females and Males
Age
18 + years
Inclusion criteria
Show details
- first pharmacy claim for Tofacitinib and then Etanercept or Adalimumab between Jan
2014 and Sep 2016 represents the index claim
- First, select patients receiving ≥1 Tofacitinib pharmacy claim (Jan 2014-Sep 2016) who
did not have a Tofacitinib claim anytime prior to index
- Patients do have >1 advanced therapy filled on index date
- Physician diagnosis of Rheumatoid Arthritis (in any position) during the 1-year
pre-index period, or on the index date
- Age 18+ years at index
Exclusion criteria
Show details
-None